Monogram Tech(MGRM.US)

Company Encyclopedia

Monogram Tech

MGRM.US

Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. The company was formerly known as Monogram Orthopaedics, Inc.

1.420 T

MGRM.USMarket value -Rank by Market Cap -/-

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Dose of uncertainty: experts wary of AI health tech gadgets on display at CES trade show

Health tech gadgets showcased at CES promise innovative solutions, such as AI-driven hormone trackers and smart scales. However, experts express concerns over their accuracy and data privacy, especially as the FDA relaxes regulations on low-risk health products. While AI can enhance healthcare, it may also perpetuate biases and misinformation. Privacy protections are limited for consumer devices, raising questions about data usage. Despite skepticism, creators argue their products address healthcare gaps, particularly in women's health, and emphasize customer privacy.

南华早报·01/08/2026 14:35

After-Hours Gainers: ALXO, GMED, ACRV, And Biotech Peers Rally On Trial Data And Earnings Updates

Several biotechnology and healthcare companies saw significant after-hours gains on Wednesday due to clinical updates and financial results. ALX Oncology Holdings (ALXO) surged 10.17% after positive Phase 2 trial data. Globus Medical (GMED) climbed 9.34% on strong preliminary sales results, while Acrivon Therapeutics (ACRV) rose 6.44% ahead of upcoming clinical data releases. Other notable gainers included RenovoRx (RNXT), AnaptysBio (ANAB), Omeros Corp (OMER), EUDA Health (EUDA), TherapeuticsMD (TXMD), and Pyxis Oncology (PYXS).

rttnews·01/08/2026 11:15

rttnews·01/08/2026 11:15

Healthcare’s biggest 2025 trends and 2026 predictions

In a recent episode, healthcare reporters discuss the significant trends from 2025 and their potential continuation into 2026. The analysis covers various factors impacting pharmaceutical and medical companies, including US government policies and M&A activity. The team reflects on the healthcare industry's evolution and forecasts for the upcoming year, emphasizing the importance of social responsibility and business intelligence in shaping future developments.

Pharmaceutical Technology·01/06/2026 18:22

Oklahoma Proton Center showcased in documentary "The Accelerator" tracing proton therapy's evolution in cancer care.

Recently, the Oklahoma Proton Center gained recognition in the highly acclaimed documentary "The Accelerator," which highlights the development of proton therapy from its inception to its significant role in cancer treatment. This documentary showcases the evolution of this advanced therapy method, shedding light on its life-saving capabilities.

Unusual Whales·01/06/2026 01:29

Study shows BIOTRONIK Neuro's remote monitoring led to high therapy use and lower explant rates, sets new device management standard.

A recent study published in Neuromodulation reveals that BIOTRONIK Neuro's remote monitoring and programming have significantly increased therapy utilization and reduced explant rates. Conducted in Lake Oswego, Ore., on January 5, 2026, the research demonstrates the positive impact of technology in healthcare, establishing a correlation between remote monitoring and improved patient outcomes.

Unusual Whales·01/05/2026 21:41